Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
Kenji Tabata
Advertisement
Kenji Tabata, PhD, is senior vice-president, head of Discovery Intelligence, Applied Research & Operations, at Japan-based pharmaceutical company Astellas.
Articles by Kenji Tabata
Advertisement
Latest Updated Articles
Digital Transformation: Accelerating Small-Molecule Drug DiscoveryPublished: December 7th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
2
Sustainability and Stability in Excipients
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
5
